Riggs Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Riggs Asset Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-165	Closed	-$8K	–	266
2016 Q1	$8K	Hold	165	–	–	0.01%	199
2015 Q4	$9K	Hold	165	–	–	﹤0.01%	202
2015 Q3	$8K	Hold	165	–	–	﹤0.01%	198
2015 Q2	$10K	Buy	+165	New	+$9.64K	0.01%	222

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Riggs Asset Management's IHE Position: Q2 2016 in Review

Riggs Asset Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2016, closing a stake of 165 shares — an estimated $8K sold.

Riggs Asset Management first reported a position in IHE in Q2 2015 and held it in 4 quarters. The position peaked at $10K in Q2 2015. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2016.

Riggs Asset Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
Riggs Asset Management sold 165 iShares US Pharmaceuticals ETF shares in Q2 2016, an estimated $8K.
Riggs Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and held it in 4 quarters.
Riggs Asset Management's iShares US Pharmaceuticals ETF position peaked at $10K in Q2 2015.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2016.

Based on Riggs Asset Management's 13F filing for Q2 2016, filed 28 Jul 2016.